BRPI0503488A - agente de tratamento para sìndrome de intestino irritável com diarréia predominante - Google Patents

agente de tratamento para sìndrome de intestino irritável com diarréia predominante

Info

Publication number
BRPI0503488A
BRPI0503488A BRPI0503488-4A BRPI0503488A BRPI0503488A BR PI0503488 A BRPI0503488 A BR PI0503488A BR PI0503488 A BRPI0503488 A BR PI0503488A BR PI0503488 A BRPI0503488 A BR PI0503488A
Authority
BR
Brazil
Prior art keywords
treatment agent
bowel syndrome
irritable bowel
diarrhea
predominant diarrhea
Prior art date
Application number
BRPI0503488-4A
Other languages
English (en)
Inventor
Akito Nishida
Akira Niwa
Yutaka Atsuta
Original Assignee
Astellas Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/JP2004/000896 external-priority patent/WO2004066998A1/ja
Priority claimed from PCT/JP2004/006657 external-priority patent/WO2005073220A1/ja
Application filed by Astellas Pharma Inc filed Critical Astellas Pharma Inc
Publication of BRPI0503488A publication Critical patent/BRPI0503488A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

"AGENTE DE TRATAMENTO PARA SìNDROME DE INTESTINO IRRITáVEL COM DIARRéIA PREDOMINANTE". Composição farmacêutica para a terapia de síndrome de intestino irritável com diarréia em pacientes masculinos e femininos, contendo de 0,001 a 0,05 mg de cloridrato de ramosetron como uma dose diária ou uma quantidade molar equivalente de ramosetron ou seu outro sal farmaceuticamente aceitável como um ingrediente ativo.
BRPI0503488-4A 2004-01-30 2005-01-27 agente de tratamento para sìndrome de intestino irritável com diarréia predominante BRPI0503488A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
PCT/JP2004/000896 WO2004066998A1 (ja) 2003-01-31 2004-01-30 安定な経口用固形医薬組成物
PCT/JP2004/006657 WO2005073220A1 (ja) 2004-01-30 2004-05-12 下痢型過敏性腸症候群治療剤
PCT/JP2005/001549 WO2005072730A1 (ja) 2004-01-30 2005-01-27 下痢型過敏性腸症候群治療剤

Publications (1)

Publication Number Publication Date
BRPI0503488A true BRPI0503488A (pt) 2006-03-07

Family

ID=34829390

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0503488-4A BRPI0503488A (pt) 2004-01-30 2005-01-27 agente de tratamento para sìndrome de intestino irritável com diarréia predominante

Country Status (8)

Country Link
AU (1) AU2005209112B2 (pt)
BR (1) BRPI0503488A (pt)
CA (1) CA2516433C (pt)
MX (1) MXPA05009025A (pt)
NO (1) NO20054002L (pt)
NZ (1) NZ541656A (pt)
RU (1) RU2314808C2 (pt)
WO (1) WO2005072730A1 (pt)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69028934T2 (de) * 1989-02-02 1997-03-20 Yamanouchi Pharma Co Ltd Tetrahydrobenzimidazol-Derivate
GB9721139D0 (en) * 1997-10-07 1997-12-03 Glaxo Group Ltd Medicaments
AR028970A1 (es) * 2000-07-26 2003-05-28 Solvay Pharm Gmbh USO DE CILANSETRON O DE SUS SALES POR ADICIoN DE A CIDOS Y/O SOLVATOS FARMACOLoGICAMENTE COMPATIBLES PARA LA OBTENCIoN DE PREPARADOS FARMACEUTICOS PARA EL TRATAMIENTO Y/O LA PROFILAXIS DEL SíNDROME DEL INTESTINO IRRITABLE

Also Published As

Publication number Publication date
CA2516433C (en) 2009-06-02
WO2005072730A1 (ja) 2005-08-11
RU2005127333A (ru) 2006-07-10
AU2005209112B2 (en) 2007-07-05
MXPA05009025A (es) 2006-04-27
RU2314808C2 (ru) 2008-01-20
CA2516433A1 (en) 2005-08-11
NO20054002D0 (no) 2005-08-29
NO20054002L (no) 2005-10-26
AU2005209112A1 (en) 2005-08-11
NZ541656A (en) 2008-05-30

Similar Documents

Publication Publication Date Title
NO20014519L (no) Apomorfin- og sildenafilpreparat
EA201270221A1 (ru) Лечение болезни крона с применением лаквинимода
MX2009003372A (es) Formas de dosificacion de pelicula no mucoadhesiva.
MXPA05004778A (es) Metodos de uso y composiciones que contienen compuestos inmunomoduladores para el tratamiento y manejo de enfermedades mieloproliferativas.
CY1107850T1 (el) Παραγωγα θειαδιαζολυλοπιπεραζiνης mε χρησιμοτητα στην αποτροπη ή στην αγωγη εναντι tου αλγους
BRPI0510895A (pt) formulação farmacêutica de 10-propargila-10-deazaaminopterina para tratamento de linfoma de célula t
NZ613291A (en) Treatment of cognitive disorders with (r)-7-chloro-n-(quinuclidin-3-yl)benzo[b]thiophene-2-carboxamide and pharmaceutically acceptable salts thereof
MX2012000275A (es) Antagonista de bomba de acido para el tratamiento de enfermedades involucradas en la motilidad gastrointestinal anormal.
NZ587202A (en) Methods for measuring a patient response upon administration of a drug and compositions thereof
UA105644C2 (uk) Способи лікування легеневих порушень складами ліпосомального амікацину
WO2007064448A3 (en) Cancer treatment using fts and 2-deoxyglucose
AR040248A1 (es) Farmaco para el tratamiento de la vejiga hiperactiva
WO2004039325A3 (en) Treatment of pain with jnk inhibitors
NZ595376A (en) Dental anesthetic comprising tetracaine and a vasoconstrictor for intranasal administration
TNSN07474A1 (en) Dosage regimen for prasugrel
RU2007119067A (ru) Средство для лечения синдрома раздраженного кишечника с преобладанием диареи
SI1677806T1 (sl) Postopki za zdravljenje akutnega in s preobremenitvijo povzročenega zvina in natega z uporabo hialuronske kisline
AR061233A1 (es) Formulacion de liberacion prolongada de naltrexona
MX341660B (es) Agonista del receptor de ghrelina para el tratamiento de caquexia.
AR075866A1 (es) Una dosis de ave5026 para el tratamiento de tromboembolismo venoso en pacientes con deterioro renal severo. uso. composicion farmaceutica.
TNSN06072A1 (en) Use of oxcarbazepine for the treatment of diabetic neuropathic pain and the improvement of sleep
BRPI0410374A (pt) composição farmacêutica que compreende valsartano
MX2010005009A (es) Uso de compuestos inmunomoduladores para el tratamiento de trastornos asociados con disfunciones endoteliales.
BRPI0503488A (pt) agente de tratamento para sìndrome de intestino irritável com diarréia predominante
NZ595798A (en) Ectoparasiticidal methods and formulations

Legal Events

Date Code Title Description
B08F Application fees: dismissal - article 86 of industrial property law

Free format text: REFERENTE A 9A ANUIDADE.

B08K Lapse as no evidence of payment of the annual fee has been furnished to inpi (acc. art. 87)

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2259 DE 22/04/2014.